Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Res ; 19(11): 1761-8, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12458685

ABSTRACT

This is a summary report of the American Association of Pharmaceutical Scientists, the Food and Drug Administration, and the United States Pharmacopoeia cosponsored workshop on "Assuring Quality and Performance of Sustained and Controlled Release Parenterals." Experts from the pharmaceutical industry, the regulatory authorities, and academia participated in this workshop to review, discuss, and debate formulation, processing, and manufacture of sustained and controlled release parenterals and identify critical process parameters and their control. Areas were identified where research is needed to understand the performance of these drug delivery systems and to assist in the development of appropriate testing procedures. Recommendations were made for future workshops, meetings, and working groups in this area.


Subject(s)
Delayed-Action Preparations/standards , Drug Industry/standards , Pharmacopoeias as Topic/standards , United States Food and Drug Administration/standards , Humans , Infusions, Parenteral/standards , United States
2.
AAPS PharmSci ; 4(2): E7, 2002.
Article in English | MEDLINE | ID: mdl-12141269

ABSTRACT

This is a summary report of the American Association of Pharmaceutical Scientists, the Food and Drug Administration and the United States Pharmacopoeia co-sponsored workshop on "Assuring Quality and Performance of Sustained and Controlled Release Parenterals." Experts from the pharmaceutical industry, the regulatory authorities and academia participated in this workshop to review, discuss and debate formulation, processing and manufacture of sustained and controlled release parenterals and identify critical process parameters and their control. Areas were identified where research is needed in order to understand the performance of these drug delivery systems and to assist in the development of appropriate testing procedures. Recommendations were made for future workshops, meetings and working groups in this area.


Subject(s)
Delayed-Action Preparations/standards , Biological Availability , Biopolymers/chemistry , Delayed-Action Preparations/classification , Delayed-Action Preparations/metabolism , Delayed-Action Preparations/pharmacokinetics , Drug Administration Routes , Drug Contamination/prevention & control , Drug Stability , Quality Control , Solvents/chemistry , Solvents/standards , Therapeutic Equivalency
SELECTION OF CITATIONS
SEARCH DETAIL
...